Xeroderma pigmentosum: when the sun burns the eyes
Aymane Ridallah, Lalla Ouafaa Cherkaoui
Corresponding author: Aymane Ridallah, University Mohammed V Souissi, Ophtalmologie A, l´hôpital des Spécialités, CHU Rabat, Maroc
Received: 13 Jun 2020 - Accepted: 03 Jul 2020 - Published: 14 Jul 2020
Domain: Ophthalmology
Keywords: Xeroderma pigmentosum, eye, carcinoma, skin, sunlight, consanguine marriage
©Aymane Ridallah et al. PAMJ Clinical Medicine (ISSN: 2707-2797). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Aymane Ridallah et al. Xeroderma pigmentosum: when the sun burns the eyes. PAMJ Clinical Medicine. 2020;3:107. [doi: 10.11604/pamj-cm.2020.3.107.24290]
Available online at: https://www.clinical-medicine.panafrican-med-journal.com//content/article/3/107/full
Xeroderma pigmentosum: when the sun burns the eyes
Aymane Ridallah1,&, Lalla Ouafaa Cherkaoui1
&Corresponding author
We report the case of a two-month-old male infant from a consanguine marriage. He had pigmented lesions on the skin of the eyelids, the face, and the neck, alternating with areas of depigmentation. An erosive appearance was found on the nose skin and lower labial mucosa. Ophthalmologically, the ocular tracking reflex was present, blepharitis was found with inflammatory palpebral swelling and bilateral ectropion; associated with conjunctival hyperemia, mucous secretions and severe dry eyes with corneal ulceration (exposure keratitis). The rest of the eye exam was normal. The prescribed treatment is based on sun protection, moistening, healing and antibiotic eye drops in both eyes, with close monitoring. Xeroderma pigmentosum (XP) is a rare genetic disease, with an autosomal recessive transmission, common in the Maghreb due to the high rate of consanguine marriage. The diagnosis of XP is clinical, defined by pigment abnormalities of skin exposed to the sun, skin neoplasia; XP is linked to a defect in the enzymes involved in repairing the oncogenic effects of ultraviolet exposure. Ocular neoplasia is most often located at the limb, cornea and conjunctiva. Prevention of tumors requires protection from sunlight. Surgical removal of tumors and self-healing of skin not exposed to the sun are the most important therapeutic measures. Treatment of complications (hyperemia, infections, and corneal opacification) is symptomatic, waiting for the arrival of the gene therapy.
Figure 1: A) inflammatory palpebral swelling, associated with ectropion of the upper eyelid and conjunctival mucopurulent secretions; B) photograph of the patient showing the presence of pigmented lesions alternating with the areas of depigmentation on the face